In the Original Investigation titled “Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels,”1 the y-axis label in Figure 1C was incorrect. It should have read “Overall survival, %.” The article has been corrected online.
Reference
- 1.Ricciuti B, Wang X, Alessi JV, et al. Association of high tumor mutation burden in non–small cell lung cancers with increased immune infiltration and improved clinical outcomes of PD-L1 blockade across PD-L1 expression levels. JAMA Oncol. 2022;8(8):1160-1168. doi: 10.1001/jamaoncol.2022.1981 [DOI] [PMC free article] [PubMed] [Google Scholar]